Cayman Pharma s.r.o.
Global Leader in cGMP Prostaglandin APIs
Hersteller von Prostaglandin-APIs: Bimatoprost, Latanoprost, Latanoprostene Bunod, Travoprost und Tafluprost zur Behandlung von Glaukom; Epoprostenol zur Behandlung von pulmonaler Hypertonie; Cloprostenol zur Brunstsynchronisation bei Nutztieren.
- Type
- brand seeking distribution
- Location
- Czechia
- Founded
- 2001
- Website
- https://www.caymanpharma.com/
- Categories
- Chemie & Kunststoffe
Listed in a source registry
Verified facts
- domain-registered (green), checked 2026-08-02 Domain registry record
- gmp-certified (green), checked 2026-08-21 ANVISA (Brazilian Health Regulatory Agency), public register of Good Manufacturing Practice certificates (CBPF)
- vat-valid (green), checked 2026-08-01 VIES (European Commission)
- lei-active (green), checked 2026-08-30 GLEIF global LEI register (golden copy)
- certificate-page-on-site (amber), checked 2026-08-30 Company's own certification page
- registered-since (green), checked 2001-12-17 ARES (Czech business register)
- directors-on-file (green), checked 2026-08-24 ARES (Czech business register)
- leadership-on-record (green), checked 2013-06-26 ARES (Czech business register)
- registry-activity (green), checked 2026-07-08 ARES
- facility-registered (green), checked 2026-08-30 European Industrial Emissions Portal (E-PRTR / IED), European Environment Agency
- export-registered (green), checked 2026-07-30 EU EORI validation (European Commission)
- registry-active-global (green), checked 2026-07-08 ARES
Claimed certifications
- Good Manufacturing Practice